中华内分泌外科杂志
中華內分泌外科雜誌
중화내분비외과잡지
CHINESE JOURNAL OF ENDOCRINE SURGERY
2015年
2期
97-100
,共4页
任敏%王本忠%陈樱%杨筱嵬%徐晓军%许骏%张敬杰%裴静
任敏%王本忠%陳櫻%楊篠嵬%徐曉軍%許駿%張敬傑%裴靜
임민%왕본충%진앵%양소외%서효군%허준%장경걸%배정
乳腺肿瘤%前哨淋巴结活组织检查%吲哚菁绿%纳米碳
乳腺腫瘤%前哨淋巴結活組織檢查%吲哚菁綠%納米碳
유선종류%전초림파결활조직검사%신타정록%납미탄
Breast neoplasms%Sentinel lymph node biopsy%Indocyanine green%Carbon nanoparticles
目的:探讨吲哚菁绿联合纳米碳作为淋巴示踪剂在乳腺癌前哨淋巴结活检手术中的应用价值。方法将112例临床腋窝淋巴结阴性的乳腺癌患者随机分为2组,56例接受吲哚菁绿联合纳米碳示踪,56例接受单药吲哚菁绿示踪。2组均进行前哨淋巴结活检手术,手术切除的前哨淋巴结送术中冰冻及常规石蜡和免疫组织化学病理检查。结果联合示踪组体外淋巴管显影率为94.6%(53/56),单药示踪组体外淋巴管显影率为96.4%(54/56)。联合组54例可见明显荧光浓聚,52例可见明显黑染淋巴结,2例无明显荧光浓聚患者可找到黑染淋巴结,4例未见黑染淋巴结可荧光显影,均成功检出前哨淋巴结,检出率100%(56/56);单药示踪组检出率92.9%(52/56)(χ2=2.3,P>0.050)。联合示踪组共检出前哨淋巴结205枚,平均(3.7±1.5)枚;单药示踪组共检出前哨淋巴结130枚,平均(2.5±1.4)枚(t=-3.5,P=0.001)。联合示踪组10例淋巴结阳性,共检出阳性淋巴结17枚;单药示踪组9例淋巴结阳性共检出阳性淋巴结12枚。结论联合应用吲哚菁绿和纳米碳进行乳腺癌前哨淋巴结活检,可实现优势互补以增加前哨淋巴结检出率和检出数,降低漏诊率和假阴性率。
目的:探討吲哚菁綠聯閤納米碳作為淋巴示蹤劑在乳腺癌前哨淋巴結活檢手術中的應用價值。方法將112例臨床腋窩淋巴結陰性的乳腺癌患者隨機分為2組,56例接受吲哚菁綠聯閤納米碳示蹤,56例接受單藥吲哚菁綠示蹤。2組均進行前哨淋巴結活檢手術,手術切除的前哨淋巴結送術中冰凍及常規石蠟和免疫組織化學病理檢查。結果聯閤示蹤組體外淋巴管顯影率為94.6%(53/56),單藥示蹤組體外淋巴管顯影率為96.4%(54/56)。聯閤組54例可見明顯熒光濃聚,52例可見明顯黑染淋巴結,2例無明顯熒光濃聚患者可找到黑染淋巴結,4例未見黑染淋巴結可熒光顯影,均成功檢齣前哨淋巴結,檢齣率100%(56/56);單藥示蹤組檢齣率92.9%(52/56)(χ2=2.3,P>0.050)。聯閤示蹤組共檢齣前哨淋巴結205枚,平均(3.7±1.5)枚;單藥示蹤組共檢齣前哨淋巴結130枚,平均(2.5±1.4)枚(t=-3.5,P=0.001)。聯閤示蹤組10例淋巴結暘性,共檢齣暘性淋巴結17枚;單藥示蹤組9例淋巴結暘性共檢齣暘性淋巴結12枚。結論聯閤應用吲哚菁綠和納米碳進行乳腺癌前哨淋巴結活檢,可實現優勢互補以增加前哨淋巴結檢齣率和檢齣數,降低漏診率和假陰性率。
목적:탐토신타정록연합납미탄작위림파시종제재유선암전초림파결활검수술중적응용개치。방법장112례림상액와림파결음성적유선암환자수궤분위2조,56례접수신타정록연합납미탄시종,56례접수단약신타정록시종。2조균진행전초림파결활검수술,수술절제적전초림파결송술중빙동급상규석사화면역조직화학병리검사。결과연합시종조체외림파관현영솔위94.6%(53/56),단약시종조체외림파관현영솔위96.4%(54/56)。연합조54례가견명현형광농취,52례가견명현흑염림파결,2례무명현형광농취환자가조도흑염림파결,4례미견흑염림파결가형광현영,균성공검출전초림파결,검출솔100%(56/56);단약시종조검출솔92.9%(52/56)(χ2=2.3,P>0.050)。연합시종조공검출전초림파결205매,평균(3.7±1.5)매;단약시종조공검출전초림파결130매,평균(2.5±1.4)매(t=-3.5,P=0.001)。연합시종조10례림파결양성,공검출양성림파결17매;단약시종조9례림파결양성공검출양성림파결12매。결론연합응용신타정록화납미탄진행유선암전초림파결활검,가실현우세호보이증가전초림파결검출솔화검출수,강저루진솔화가음성솔。
Objective To evaluate intraoperative tracing of sentinel lymph nodes ( SLNs) by fluorescence imaging combined with carbon nanoparticles .Methods 112 breast cancer patients eligible for sentinel lymph node biopsy were randomly assigned to the combination group (56 cases)receiving indocyanine green (ICG)and carbon nanoparticles as the lymphatic mapping tracers and ICG alone group (56 cases).Intraoperative frozen sec-tion was performed , followed by conventional histopathology .Results In the combination group , subcutaneous lymphatic vessels were successfully visualized in 53 patients and the detection rate was 94.6%(53/56).The flu-orescence SLNs were successfully detected in 54 patients and the detection rate was 96.4%(54/56)in ICG alone group.In the combination group , SLNs were successfully identified in 54 patients by fluorescence and 52 patients by black dyed, and the SLNs detection rate was 100%(56/56).While in the ICG alone group, the SLNs were found in 52 patients and the detection rate was 92.9%(52/56)(χ2 =2.3, P>0.050).The average number of detected SLNs was 3.7 ±1.5 ( 205/56 ) in combination group vs 2.5 ±1.4 ( 130/52 ) in ICG alone group ( t =-3.5, P=0.001).17 metastatic SLNs were found in 10 patients in the combination group vs 12 metastatic SLNs in 9 patients in ICG alone group .Conclusion Combination of ICG and carbon nanoparticles for mapping sentinel lymph nodes in breast cancer patients can increase the number of SLNs detected and the detection rate , reducing the rate of misdiagnosis and false negative rate .